We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$11.8B
AUM Growth
+$11.7B
Cap. Flow
+$973M
Cap. Flow %
8.28%
Top 10 Hldgs %
24.41%
Holding
296
New
40
Increased
100
Reduced
97
Closed
30

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$166M
2
AMGN icon
Amgen
AMGN
+$123M
3
ADSK icon
Autodesk
ADSK
+$114M
4
UNH icon
UnitedHealth
UNH
+$103M
5
MRK icon
Merck
MRK
+$102M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$78.6M
2
AMD icon
Advanced Micro Devices
AMD
+$74.2M
3
TMO icon
Thermo Fisher Scientific
TMO
+$65.6M
4
UNP icon
Union Pacific
UNP
+$36.4M
5
ILMN icon
Illumina
ILMN
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 24.57%
2 Financials 22.21%
3 Healthcare 21.91%
4 Communication Services 9.53%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTG icon
151
Heritage Insurance Holdings
HRTG
$884M
$19.3M 0.16%
1,300,000
– –
AUPH icon
152
Aurinia Pharmaceuticals
AUPH
$1.96B
$18.7M 0.16%
2,811,516
+211,316
+8% +$1.19M
DATA
153
DELISTED
Tableau Software, Inc.
DATA
$18.1M 0.15%
161,883
-97,931
-38% -$10.6M
PPLI
154
People Inc
PPLI
$3.21B
$18M 0.15%
463,837
+127,094
+38% +$4.12M
AVNS icon
155
Avanos Medical
AVNS
$16.7M 0.14%
+243,104
New +$15.6M
MANU icon
156
Manchester United
MANU
$3.96B
$16.5M 0.14%
733,651
+18,816
+3% +$429K
TD icon
157
Toronto Dominion Bank
TD
$196B
$16.3M 0.14%
233,430
-967
-0.4% -$57.6K
DGX icon
158
Quest Diagnostics
DGX
$26.1B
$16.1M 0.14%
+149,254
New +$16.4M
GILD icon
159
Gilead Sciences
GILD
$165B
$15.4M 0.13%
200,104
+9,104
+5% +$688K
PNC icon
160
PNC Financial Services
PNC
$99.9B
$15.2M 0.13%
111,274
+11,786
+12% +$1.68M
GRFS
161
Grifois
GRFS
$5.38B
$15M 0.13%
+703,370
New +$14.8M
BMRN icon
162
BioMarin Pharmaceuticals
BMRN
$11.9B
$15M 0.13%
154,370
-57,130
-27% -$5.7M
ONC
163
BeOne Medicines Ltd
ONC
$34.1B
$14.6M 0.12%
85,000
+10,000
+13% +$1.68M
AZPN
164
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$14.3M 0.12%
125,949
-30,191
-19% -$3.44M
UBS icon
165
UBS Group
UBS
$169B
$13.9M 0.12%
858,730
-213,684
-20% -$3.36M
PCRX icon
166
Pacira BioSciences
PCRX
$1.06B
$13.9M 0.12%
+281,824
New +$12.2M
AVEO
167
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$13.6M 0.12%
409,582
-345,685
-46% -$8.88M
SPOT icon
168
Spotify
SPOT
$104B
$13.1M 0.11%
+72,472
New +$13.3M
BDX icon
169
Becton Dickinson
BDX
$45.4B
$13.1M 0.11%
51,277
-37,898
-42% -$9.34M
RACE icon
170
Ferrari
RACE
$67.8B
$13M 0.11%
87,070
-69,256
-44% -$9.11M
ARCC icon
171
Ares Capital
ARCC
$13.7B
$12.6M 0.11%
731,732
– –
BX icon
172
Blackstone
BX
$105B
$12.1M 0.1%
317,129
-1,365
-0.4% -$49.3K
FRC
173
DELISTED
First Republic Bank
FRC
$11.8M 0.1%
122,653
-1,017
-0.8% -$102K
BNFT
174
DELISTED
Benefitfocus, Inc.
BNFT
$11.5M 0.1%
+285,489
New +$11M
SLRC icon
175
SLR Investment Corp
SLRC
$717M
$10.8M 0.09%
503,278
– –
5 6
7
8 9

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Polar Capital held 296 positions worth $11.8B, up 70,685% from $16.6M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $973M of net new capital in Q3 2018, opening 40 new positions and adding to 100 existing holdings. Its largest new stake was Johnson & Johnson: 1,250,000 shares worth $173M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $78.6M trimmed.

  • Polar Capital's largest Q3 2018 buy was Johnson & Johnson: 1,250,000 shares worth $173M.
  • Polar Capital added most to UnitedHealth in Q3 2018, an estimated $103M increase.
  • Polar Capital's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $78.6M.
  • Polar Capital fully exited Amdocs in Q3 2018, selling an estimated $46.6K.
  • Polar Capital's ten largest holdings make up 24% of its $11.8B portfolio in Q3 2018.
  • Polar Capital opened 40 new positions and closed 30 in Q3 2018.
  • Polar Capital's portfolio value rose 70,685% quarter-over-quarter to $11.8B.

Based on Polar Capital's 13F filing for Q3 2018, filed 14 Nov 2018.